Note: This page has adverse effects data for the common medication calcitriol. It is feasible that several of the dosage forms included here may not apply to the brand name Rocaltrol.
It is feasible that some negative effects of Rocaltrol may not have been stated. These could be stated to the FDA below. Always get in touch with a health care specialist for clinical recommendations.
Too much vitamin D intake (early manifestations): weakness, headache, somnolence, queasiness, dry mouth, bone tissue, muscle or constipation discomfort, metallic taste.
Too much vitamin D consumption (late manifestations): polyuria, polydipsia, anorexia, weight reduction, nocturia, calcific conjunctivitis, pancreatitis, photophobia, rhinorrhea, pruritus, hyperthermia, reduced sex drive, raised BUN, albuminuria,, raised AST, raised ALT, ectopic calcification, nephrocalcinosis, hypertension, heart arrhythmias, dystrophy, sensory disruptions, dehydration, aloofness, arrested growth, urinary tract infections.
Early signs and also symptoms of hypercalcemia include frustration, anorexia, queasiness, vomiting, metallic taste, irregularity, stomach aches, dry mouth, weak point, bone tissue, tiredness and also muscular tissue discomfort, ataxia, tinnitus, stomach discomfort, and vertigo. Later on hypercalcemia could cause pruritus, psychological confusion, coma, elevated hepatic transaminase degrees, high blood pressure, heart arrhythmias, seizures, metastatic calcification, and renal deficiency manifested by polyuria, proteinuria, nocturia, and polydipsia and also raised BUN. In one research study, the incidence of hypercalcemia was lesser (50 % vs 80 %) when calcitriol (the energetic ingredient included in Rocaltrol) was provided at evening as opposed to early morning administration. Hypercalcemia also appears to occur more generally in people obtaining intermittent vs. constant therapy and also in oral vs. intravenous therapy. Because the urinary excretion of calcium could not make up for boosts in lotion calcium, individuals with renal failure are much more vulnerable to the advancement of hypercalcemia. Increased phosphate absorption might be detrimental in clients with chronic renal failure and also hyperphosphatemia. [Ref]